These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33955200)

  • 41. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
    Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K
    Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling.
    Tian N; Cheng H; Du Y; Wang X; Lei Y; Liu X; Chen M; Xu Z; Wang L; Yin H; Fu R; Li D; Zhou P; Lu L; Yin Z; Dai SM; Li B
    J Autoimmun; 2024 Jul; 147():103233. PubMed ID: 38797049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tree shrews as a new animal model for systemic sclerosis research.
    Zheng L; Chen S; Wu Q; Li X; Zeng W; Dong F; An W; Qin F; Lei L; Zhao C
    Front Immunol; 2024; 15():1315198. PubMed ID: 38343538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
    Yoshizaki A; Taniguchi T; Saigusa R; Fukasawa T; Ebata S; Numajiri H; Nakamura K; Yamashita T; Takahashi T; Toyama T; Asano Y; Tedder TF; Sato S
    Ann Rheum Dis; 2016 Oct; 75(10):1858-65. PubMed ID: 26567180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial cells recruit macrophages and contribute to a fibrotic milieu in bleomycin lung injury.
    Leach HG; Chrobak I; Han R; Trojanowska M
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1093-101. PubMed ID: 23885794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice.
    Akashi K; Saegusa J; Sendo S; Nishimura K; Okano T; Yagi K; Yanagisawa M; Emoto N; Morinobu A
    Arthritis Res Ther; 2016 May; 18(1):113. PubMed ID: 27209208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression and significance of Th17 cells and related cytokines in a murine model of systemic sclerosis].
    Lei L; Zhong XN; Zhao C; Mi CD; Li JQ; Zeng JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):259-64. PubMed ID: 22517000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.
    Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK
    Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human Skin.
    Trinh-Minh T; Györfi AH; Tomcik M; Tran-Manh C; Zhou X; Dickel N; Tümerdem BS; Kreuter A; Burmann SN; Borchert SV; Hussain RI; Hallén J; Klingelhöfer J; Kunz M; Distler JHW
    Arthritis Rheumatol; 2024 May; 76(5):783-795. PubMed ID: 38108109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cells.
    Ishikawa H; Takeda K; Okamoto A; Matsuo S; Isobe K
    J Invest Dermatol; 2009 Jul; 129(7):1688-95. PubMed ID: 19158840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic effect of adipose tissue-derived stem cells on bleomycin-induced mice of scleroderma].
    Dou JL; Bai L; Pang CY; Zhang WL; Zhang W; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):970-976. PubMed ID: 27987499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GRB2 serves as a viable target against skin fibrosis in systemic sclerosis by regulating endothelial cell apoptosis.
    Huang Y; Zhao H; Shi X; Liu J; Lin JM; Ma Q; Jiang S; Pu W; Ma Y; Liu J; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2023 Sep; 111(3):109-119. PubMed ID: 37661474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis.
    Watanabe T; Nishimoto T; Mlakar L; Heywood J; Malaab M; Hoffman S; Feghali-Bostwick C
    PLoS One; 2017; 12(6):e0179917. PubMed ID: 28651005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
    Wu MH; Yokozeki H; Takagawa S; Yamamoto T; Satoh T; Kaneda Y; Katayama I; Nishioka K
    Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-1β-Activated Microvascular Endothelial Cells Promote DC-SIGN-Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis.
    Laurent P; Lapoirie J; Leleu D; Levionnois E; Grenier C; Jurado-Mestre B; Lazaro E; Duffau P; Richez C; Seneschal J; Pellegrin JL; Constans J; Schaeverbeke T; Douchet I; Duluc D; Pradeu T; Chizzolini C; Blanco P; Truchetet ME; Contin-Bordes C;
    Arthritis Rheumatol; 2022 Jun; 74(6):1013-1026. PubMed ID: 34962361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD22 and CD72 contribute to the development of scleroderma in a murine model.
    Zhao C; Matsushita T; Ha Nguyen VT; Tennichi M; Fujimoto M; Takehara K; Hamaguchi Y
    J Dermatol Sci; 2020 Jan; 97(1):66-76. PubMed ID: 31883832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
    Ponsoye M; Frantz C; Ruzehaji N; Nicco C; Elhai M; Ruiz B; Cauvet A; Pezet S; Brandely ML; Batteux F; Allanore Y; Avouac J
    Ann Rheum Dis; 2016 Dec; 75(12):2142-2149. PubMed ID: 26912566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.